Exploiting molecular targets in pancreatic cancer

This publication has 74 references indexed in Scilit:

• Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
  New England Journal of Medicine, 2001
• Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin
  Oncogene, 2001
• The rapamycin-sensitive signal transduction pathway as a target for cancer therapy
  Oncogene, 2000
• Effect of Angiostatin on Liver Metastasis of Pancreatic Cancer in Hamsters
  Japanese Journal of Cancer Research, 2000
• ZD1839 (???Iressa???)*,??? as an Anticancer Agent
  Drugs, 2000
• What Is the True Rate of K-ras Mutation in Carcinoma of the Pancreas?
  Pancreas, 1998
• The Biologic Effects of C225, A Chimeric Monoclonal Antibody to the EGFR, on Human Prostate Carcinoma
  Journal of Immunotherapy, 1996
• p53 Status and the Efficacy of Cancer Therapy in Vivo
  Science, 1994
• Activation of the MAP kinase pathway by the protein kinase raf
  Cell, 1992
• Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
  Published by Elsevier ,1988